about
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesProteinuria in paediatric patients with human immunodeficiency virus infectionBone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San FranciscoThe effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicityLow body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse eventsA Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 InfectionPilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimenTenofovir-associated bone density loss.Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureAging, human immunodeficiency virus, and bone health.Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, MalawiTotal protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strainsVirological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionTenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis BTenofovir-associated renal dysfunction in clinical practice: An observational cohort from western IndiaManagement of HIV infection in treatment-naive patients: a review of the most current recommendations.Risk factors for vitamin D deficiency among veterans with and without HIV infectionPharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.Woman with congenital HIV infection and medication-induced Fanconi syndrome.Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenImpact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis BBone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir.Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function.Tenofovir and bone health.Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patientsHIV pre-exposure prophylaxis for women.Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-EmtricitabineAssociation of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure.
P2860
Q27000080-50F70A25-AA16-43FF-8F25-7F0DC72B1403Q27009315-020510FB-C4A6-4C92-A34D-EB512D0C27CCQ28476730-3828DB35-0954-4D34-BDA2-EB5E32A88A6FQ28483688-80D5E96F-7CB0-4FFA-8151-A9DD042F3BCAQ28535587-81193C2C-DA89-4599-BAD4-1316345D1825Q28552839-27A56008-A5DD-455E-841E-956223125149Q28741214-1963359E-6202-4C2D-AAFD-42F9F08829BEQ33635034-9B200C42-4501-48A1-9227-B6ED464F7421Q33880241-F4B907F7-CE8E-42CA-9977-09C013CEA29CQ34160511-F852A512-804E-4672-B81D-EF3FB6199025Q34358152-BF1A90C4-0629-403B-8F34-FB7A23C2ACCAQ34375843-5656EFC1-0D97-4D55-BB30-BE44E10E53ABQ34409132-BA51768F-A9D3-4FC1-BBE2-1460E0649F53Q34478840-B49B7C5B-8A5A-4E70-B540-70C3CD1CC67DQ34596639-F07E3070-4CF1-4E9D-AC5C-E37D72E3B33CQ34906495-BB715041-5B7B-40EE-9226-F10F1ACC6A72Q35016654-950CD84B-0164-4EA2-85B2-5ABAC711ACF6Q35105892-96511712-7A7D-436E-96E9-0FCDCFD90C28Q35117296-B6D1C920-784D-40DF-AD51-3FD076C3E3DFQ35188723-3FE3C751-27D6-419B-9ED9-A4DAE1A59122Q35510622-C5104261-A689-43AD-9944-E2583A268E26Q35557216-E8F7DD1A-4962-4478-80A7-4644D6FDBA35Q35557338-E8934F8C-0ADB-45E6-956D-A0E51E4567DAQ35636495-5301AF62-90F5-4FE5-B4F6-93D9DECBD7EBQ35815286-7AF0FFB4-B400-43E8-B6F0-C5B9EED076E3Q35869263-1B573541-62D7-4562-A1BD-C26265F56FEBQ36033710-BE3186CE-4DF9-4E1B-A3FB-F8CD2F212CC4Q36070335-B017CF0C-B712-4E78-AB13-90E328E2B13CQ36151245-C942399E-0BA3-47A4-9E08-8C0427D9D98FQ36584980-74D17445-BCB0-4EDC-8262-F94E2C6AD039Q36586078-AB340693-8E2A-474C-8027-249A8DF1E735Q36651106-7A0F0430-5710-452E-A2C1-78CFA54BCB43Q36757558-C765293A-3B65-4501-A9E5-DBBA8579A37CQ36833961-0838EEBE-A12C-4D19-B2FC-BBB858D7CC51Q36910943-C95E11EA-8870-4B4B-BDEB-02253CF8F599Q36931691-DA9CEE4A-ACAF-4BDB-9762-2338601FF385Q37141403-470860B7-FD53-47F8-9FAE-9E89A20E9E87Q37203781-D00A9065-13AD-4CDA-B502-0F74FCB42E5DQ37263395-978F79B3-0354-41BB-8950-DCE46C94D7C8Q37588780-39F924A1-3CC7-4811-852E-2DF1A10BC3C2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tenofovir-associated renal and bone toxicity.
@en
Tenofovir-associated renal and bone toxicity.
@nl
type
label
Tenofovir-associated renal and bone toxicity.
@en
Tenofovir-associated renal and bone toxicity.
@nl
prefLabel
Tenofovir-associated renal and bone toxicity.
@en
Tenofovir-associated renal and bone toxicity.
@nl
P2093
P1433
P1476
Tenofovir-associated renal and bone toxicity.
@en
P2093
Clare L N Woodward
I G Williams
J O Connolly
M A Johnson
S G Edwards
P304
P356
10.1111/J.1468-1293.2009.00716.X
P50
P577
2009-05-06T00:00:00Z